Journal
DRUG DELIVERY AND TRANSLATIONAL RESEARCH
Volume 11, Issue 6, Pages 2496-2519Publisher
SPRINGER HEIDELBERG
DOI: 10.1007/s13346-021-00992-9
Keywords
Chitosan; Chondroitin sulfate; Hyaluronic acid; Thermosensitive hydrogels; Rheumatoid arthritis
Ask authors/readers for more resources
Intra-articular drug delivery using smart hydrogels loaded with nanoencapsulated drugs shows promising results in treating rheumatoid arthritis by targeting inflamed joints. Experimental evidence demonstrates that HA-coated nanostructured lipid carriers result in faster recovery and better joint healing outcomes.
Intra-articular drug delivery represents a tempting strategy for local treatment of rheumatoid arthritis. Targeting drugs to inflamed joints bypasses systemic-related side effects. Albeit, rapid drug clearance and short joint residence limit intra-articular administration. Herein, injectable smart hydrogels comprising free/nanoencapsulated leflunomide (LEF) were developed. Nanostructured lipid carriers (NLCs), 200-300 nm, were coated with either chondroitin sulfate (CHS), hyaluronic acid (HA), or chitosan (CS) to provide joint targetability. Coated NLCs were incorporated in either hyaluronic/pluronic (HP) or chitosan/beta-glycerophosphate (CS/beta GP) hydrogels. Optimized systems ensured convenient gelation time (14-100 s), injectability (5-15 s), formulation-dependent mechanical strength, and extended LEF release up to 51 days. In vivo intra-articular injection in induced arthritis rat model revealed that rats treated with HA-coated NLCs showed the fastest recovery. Histopathological examination demonstrated perfect joint healing in case of HA-coated LEF-NLCs in CS/beta GP thermogel manifested as minor erosion of subchondral bone, improved intensity of extracellular matrix, cartilage thickness, and chondrocyte number. Both HA- and CHS-coated NLCs reduced TNE-alpha level 4-5-fold relative to positive control. The feat would be achieved via active targeting to CD44 receptors overexpressed in the articular tissue, limiting chondrocyte apoptosis together with innate synergistic targetability by promoting chondrocyte proliferation and neovascularization, inhibiting the production of pro-inflammatory cytokines, thus enhancing cartilaginous tissue repair.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available